Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Harris

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
European Heart Journal Open|November 23, 2022
Identifying unmet antithrombotic therapeutic need, and implications for stroke and systemic embolism in atrial fibrillation patients: a population-scale longitudinal studyFatemeh Torabi, Daniel E Harris, Owen Bodger, et al.
European Journal of Preventive Cardiology|July 22, 2024
Trends in atherosclerotic cardiovascular disease and lipid management: a population-level observational cohort study in WalesDaniel E Harris, Daniel King, Ashley Akbari, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 28, 2019
An observational study of international normalized ratio control according to NICE criteria in patients with non-valvular atrial fibrillation: the SAIL Warfarin Out of Range Descriptors Study (SWORDS)Daniel E Harris, Daniel Thayer, Ting Wang, et al.
European Journal of Preventive Cardiology|July 23, 2021
Achievement of European guideline-recommended lipid levels post-percutaneous coronary intervention: A population-level observational cohort studyDaniel E Harris, Arron Lacey, Ashley Akbari, et al.
European Heart Journal Open|December 26, 2025
Management of atherosclerotic cardiovascular disease risk in diabetes mellitus patients: a population-level observational cohort study in WalesDaniel King, Ashley Akbari, Mike B Gravenor, et al.
European Heart Journal Open|May 5, 2023
SAIL study of stroke, systemic embolism and bleeding outcomes with warfarin anticoagulation in non-valvular atrial fibrillation (S<sup>4</sup>-BOW-AF)Daniel E Harris, Fatemeh Torabi, Daniel Mallory, et al.
Journal of the American Heart Association|October 30, 2019
Early Discontinuation of P2Y<sub>12</sub> Antagonists and Adverse Clinical Events Post-Percutaneous Coronary Intervention: A Hospital and Primary Care Linked CohortDaniel E Harris, Arron Lacey, Ashley Akbari, et al.
European Heart Journal Open|May 19, 2023
Incident atrial fibrillation and adverse clinical outcomes during extended follow-up of participants recruited to the remote heart rhythm sampling using the AliveCor heart monitor to screen for atrial fibrillation: the REHEARSE-AF studyElizabeth A Ellins, Kathie Wareham, Daniel E Harris, et al.
International Journal of Population Data Science|May 29, 2026
Cohort profile: Creation of an e-cohort to Address the Evaluation of Population Secondary Prevention Quality and Outcomes Post-Stroke (ESP-QOPS) in WalesDaniel King, Elizabeth A Ellins, Hywel T Evans, et al.
Plos One|February 25, 2022
Achievement of European Society of Cardiology/European Atherosclerosis Society lipid targets in very high-risk patients: Influence of depression and sexElizabeth A Ellins, Daniel E Harris, Arron Lacey, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
European Heart Journal Open|November 23, 2022
Identifying unmet antithrombotic therapeutic need, and implications for stroke and systemic embolism in atrial fibrillation patients: a population-scale longitudinal studyFatemeh Torabi, Daniel E Harris, Owen Bodger, et al.
European Journal of Preventive Cardiology|July 22, 2024
Trends in atherosclerotic cardiovascular disease and lipid management: a population-level observational cohort study in WalesDaniel E Harris, Daniel King, Ashley Akbari, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|November 28, 2019
An observational study of international normalized ratio control according to NICE criteria in patients with non-valvular atrial fibrillation: the SAIL Warfarin Out of Range Descriptors Study (SWORDS)Daniel E Harris, Daniel Thayer, Ting Wang, et al.
European Journal of Preventive Cardiology|July 23, 2021
Achievement of European guideline-recommended lipid levels post-percutaneous coronary intervention: A population-level observational cohort studyDaniel E Harris, Arron Lacey, Ashley Akbari, et al.
European Heart Journal Open|December 26, 2025
Management of atherosclerotic cardiovascular disease risk in diabetes mellitus patients: a population-level observational cohort study in WalesDaniel King, Ashley Akbari, Mike B Gravenor, et al.
European Heart Journal Open|May 5, 2023
SAIL study of stroke, systemic embolism and bleeding outcomes with warfarin anticoagulation in non-valvular atrial fibrillation (S<sup>4</sup>-BOW-AF)Daniel E Harris, Fatemeh Torabi, Daniel Mallory, et al.
Journal of the American Heart Association|October 30, 2019
Early Discontinuation of P2Y<sub>12</sub> Antagonists and Adverse Clinical Events Post-Percutaneous Coronary Intervention: A Hospital and Primary Care Linked CohortDaniel E Harris, Arron Lacey, Ashley Akbari, et al.
European Heart Journal Open|May 19, 2023
Incident atrial fibrillation and adverse clinical outcomes during extended follow-up of participants recruited to the remote heart rhythm sampling using the AliveCor heart monitor to screen for atrial fibrillation: the REHEARSE-AF studyElizabeth A Ellins, Kathie Wareham, Daniel E Harris, et al.
International Journal of Population Data Science|May 29, 2026
Cohort profile: Creation of an e-cohort to Address the Evaluation of Population Secondary Prevention Quality and Outcomes Post-Stroke (ESP-QOPS) in WalesDaniel King, Elizabeth A Ellins, Hywel T Evans, et al.
Plos One|February 25, 2022
Achievement of European Society of Cardiology/European Atherosclerosis Society lipid targets in very high-risk patients: Influence of depression and sexElizabeth A Ellins, Daniel E Harris, Arron Lacey, et al.
Pageof 1